1[1]Stein B,Weintraub W,Gebhart S,et al.Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.Circulation,1995,91:979-989
2[2]Kip KE,Faxon D,Detre K,et al.Coronary angioplasty in diabetic patients.The national Heart.Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.Circulation,1996,94:1818-1825
3[4]Levine GN,Jacobs A,Keeler G,et al.Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-1).Am J Cardiol,1997,79:748-755
4[5]Halon DA,Merdlcr a,Flugelman M,et al.Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty(the LDCMC registry).Lady Davis Carmel Medical Center.Am J Cardiol,1998,82:547-553
5[6]Weintraub WS,Kosinski A,Brown C,et al.Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol,1993,21:6-14
6[7]Rensing B,Hermans W,Vos J,et al.Luminal narrowing after percutaneous transluminal coronary angioplasty.A study of clinical,procedural,adn lesional factors related to long-term angiographic outcome.Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism(CARPORT)Study Group.Circulation,1993,88:975-985
7[8]Quigley P,Hlatky M,Hinohara T,et al.Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis.Am J Cardiol,1989,63:409-413
8[9]Lambert M,Bonan R,Cote G,et al.Multiple coronary angioplasty:a model to discriminate systemic and procedural factors related to restenosis.J Am Coll Cardiol,1988,12:310-314
